Sale!

GFPT1 Gene Myasthenia Congenital with Tubular Aggregates 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GFPT1 Gene Myasthenia Congenital with Tubular Aggregates 1 genetic test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the GFPT1 gene, which have been linked to a rare form of congenital myasthenia. Congenital myasthenia is a group of conditions that result in muscle weakness and fatigue, often from birth. The specific subtype associated with mutations in the GFPT1 gene is characterized by the presence of tubular aggregates in muscle cells, which can be observed under a microscope.

The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic variations in the GFPT1 gene that are known to cause the condition. This genetic testing is crucial for the accurate diagnosis and management of patients with suspected congenital myasthenia, as it helps in tailoring the most effective treatment strategies for the individual.

At DNA Labs UAE, the cost of the GFPT1 Gene Myasthenia Congenital with Tubular Aggregates 1 genetic test is 4400 AED. This price includes the full testing procedure and a comprehensive report of the findings. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and care plans.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test

Test Name: GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GFPT1 Gene Myasthenia congenital with tubular aggregates 1.

Test Details: The GFPT1 gene is associated with a condition called Myasthenia Congenita with Tubular Aggregates 1 (MCTA1). This is a rare genetic disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze a person’s DNA to identify genetic variations or mutations that may be associated with certain diseases or conditions. In the case of MCTA1, NGS genetic testing can be used to identify mutations in the GFPT1 gene that are responsible for causing the condition. By performing this genetic test, healthcare professionals can provide an accurate diagnosis for individuals suspected of having MCTA1. This information can help guide treatment decisions and provide important information for genetic counseling and family planning.

Note: Genetic testing for MCTA1 is typically performed by healthcare professionals with expertise in genetics, such as genetic counselors or clinical geneticists. If you suspect that you or someone you know may have MCTA1, it is recommended to consult with a healthcare professional who can guide you through the testing process.

Test Name GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GFPT1 Gene Myasthenia congenital with tubular aggregates 1
Test Details

The GFPT1 gene is associated with a condition called Myasthenia Congenita with Tubular Aggregates 1 (MCTA1). This is a rare genetic disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue.

NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze a person’s DNA to identify genetic variations or mutations that may be associated with certain diseases or conditions. In the case of MCTA1, NGS genetic testing can be used to identify mutations in the GFPT1 gene that are responsible for causing the condition.

By performing this genetic test, healthcare professionals can provide an accurate diagnosis for individuals suspected of having MCTA1. This information can help guide treatment decisions and provide important information for genetic counseling and family planning.

It’s important to note that genetic testing for MCTA1 is typically performed by healthcare professionals with expertise in genetics, such as genetic counselors or clinical geneticists. If you suspect that you or someone you know may have MCTA1, it is recommended to consult with a healthcare professional who can guide you through the testing process.